BRC News

Researchers have applied a method based on technology used in the military to detect submarines to record brain activity in epilepsy – saying it could improve the quality of diagnosis.

UCLH and UCL researchers are applying artificial intelligence (AI) to improve and personalise treatment of juvenile lupus (known in full as Juvenile Onset Systemic Lupus Erythematosus, or JSLE).

A cutting-edge MRI technique to detect iron deposits in different brain regions can track declines in thinking, memory and movement in people with Parkinson’s disease, finds a new UCL-led study.

An initiative to tackle anti-microbial resistance (AMR) has announced two funding calls at its official launch this week.

High tech wearable devices that monitor patients’ vital signs and spot early indicators of deterioration are being trialled as part of an international project involving five European hospitals including UCLH.

A UCL-led centre of excellence investigating blood-borne viruses (BBVs) and sexually transmitted infections (STIs) is one of the Health Protection Research Units (HPRUs) across the UK that will share in a £58.7 million research investment from the NIHR.

Quitting smoking could do more than just stop further damage to the lungs. It could also allow new, healthy cells to actively replenish the lining of our airways which could protect against cancer, according to UCL, UCLH and Wellcome Sanger Institute researchers funded by Cancer Research UK.

Results of a clinical trial in progressive multiple sclerosis (MS) in which 3 different drugs were tested at the same time, instead of 1 by 1 by 1 have been published.

Scientists have shown a blood test could predict the onset of tuberculosis (TB) three to six months before people become unwell, a finding which could help better target antibiotics and save countless lives.

BRC deafness and hearing problems researchers will work in partnership with a unique medicines discovery collaboration launched today to fast-track development of treatments for hearing loss and tinnitus.

First-time marathon runners who trained for and completed a marathon saw their blood pressure go down and developed more elastic arteries – equivalent to a 4-year reduction in their ‘arterial age’ – according to a study by UCL and Barts Health NHS Trust.

A UCLH and UCL study has identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.

UCLH today joined the UK Health Data Research Alliance.

A new clinical trial investigating whether immunotherapy drug Ustekinumab could help to preserve insulin-producing cells in adolescents with newly diagnosed Type 1 diabetes (T1D) is now open at the NIHR UCLH Clinical Research Facility.

BRC Operations Manager Dr Sarah Watters reflects on the third BRC after-hours event in this blog.